Atlas Trials

A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer

Clinical trial NCT06395753 · COMPLETED

Trial details

NCT number
NCT06395753
Sponsor
Debiopharm International SA
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2024-05-23
Primary completion
2026-06-24
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.